Ryan Grim reports that the biggest and best-funded organizations in the liberal peace movement, primarily MoveOn and the groups in its Americans Against Escalation in Iraq (AAEI) coalition, are no longer advocating that Congress end the war. This year "the groups instead will lower their sights and push for legislation to prevent President Bush from entering into a long-term agreement with the Iraqi government that could keep significant numbers of troops in Iraq for years to come. ... The groups believe this switch in strategy can draw contrasts with Republicans that will help Democrats gain ground in November." AAEI's PR spokesperson, Moira Mack of Hildebrand Tewes Consulting, called it "the perfect legislative opportunity." In other words, as CMD's Sheldon Rampton and John Stauber noted last March, for MoveOn and other Democrat-aligned peace groups it's not about ending the war, it's about electing Democrats. Most of the tens of millions of dollars that MoveOn and AAEI have spent lobbying and organizing for "peace" has been directed at pressuring and embarrassing pro-war Republicans, while the Democratic Congress has continued to fund the war and pro-war Democrats have generally been given a pass.

The pharmaceutical industry is using a novel technique to cheer up people who suffer from clinical depression -- only publishing favorable studies about the effects of its antidepressant medications. A new study in the New England Journal of Medicine looked at 74 studies registered with the U.S. Food and Drug Administration. Of the 36 favorable studies, all but one was published. Of the 37 unfavorable studies, all but three were "either not published (22 studies) or published in a way that, in our opinion, conveyed a positive outcome (11 studies)." As Newsweek science writer Sharon Begley observes, "The result of this selective publication is no less than a distortion of science and -- since these are studies that drive what doctors advise their patients to do and what patients ask for -- a perversion of the biomedical system in which untainted results are supposed to benefit public health."